Awardee OrganizationWAKE FOREST UNIVERSITY HEALTH SCIENCES
Description
Abstract Text
DESCRIPTION (provided by applicant):
Parkinson's disease (PD) is a degenerative neurological disorder affecting millions of patients all around the world. Renewed use of the deep brain stimulation (DBS) method provides a new opportunity for treating PD. A key issue to improve the treatment is to fully understand the neural mechanisms underlying the therapeutic effects of DBS. In this proposed study, two unique techniques developed in our laboratory: the chronic multiple-channel single unit recording and rat model of DBS, will be employed to study the neural responses in multiple basal ganglia regions during behaviorally effective DBS in rat model of Parkinsonism. A first objective is to establish a rodent model of DBS in Parkinsonian conditions. The effects of DBS will be evaluated in dopamine lesioned rats performing treadmill locomotion and limb use asymmetry tests. Locomotor d deficits during treadmill walking and imbalance usage of forelimb in vertical exploratory behaviors will develop after unilateral dopamine lesion. High frequency stimulation (HFS) of the subthalamic nucleus (STN) and the substantia nigra pars reticulata (SNr) will then be applied to alleviate these motor abnormalities. The degree of dopamine depletion in the basal ganglia will be detected by immunohistochemical staining of dopamine marker and this result will be correlated with the severity of motor deficits and DBS effects. Second, the basal ganglia neural responses following a dopamine lesion and during behaviorally effective HFS will be examined. Single neural activity and local field potential in the striatum globus pallidus, STN and SNr will be recorded simultaneously in a 64 channel recording system in the rat performing these behavioral tests. Neural responses following dopamine lesion will help us to understand the pathophysiologic process of developing Parkinsonian syndromes while the neural responses during behaviorally effective HFS will shed light on how DBS can restore normal information processing in the basal ganglia neural circuits that are disrupted following dopamine lesion. Several important improvements on recording and stimulation techniques will be made in cooperation with Biographic Inc. to achieve optimal conditions for high frequency stimulation and artifact free recording. The goal of this study is to explore the basic neural mechanism underlying the therapeutic effects of DBS and the knowledge obtained form this study will help us to improve the clinical treatment of PD with DBS method.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Parkinson's diseasebasal gangliabehavior testbrain electrical activitybrain electronic stimulatordisease /disorder modeldopamineexperimental brain lesionimmunocytochemistrylaboratory ratlenticular nucleusneural information processingneuronsneurophysiologyprosencephalonpsychomotor functionsubstantia nigra
National Institute of Neurological Disorders and Stroke
CFDA Code
853
DUNS Number
937727907
UEI
SN7KD2UK7GC5
Project Start Date
01-September-2002
Project End Date
31-July-2007
Budget Start Date
01-August-2003
Budget End Date
31-July-2004
Project Funding Information for 2003
Total Funding
$265,240
Direct Costs
$190,000
Indirect Costs
$75,240
Year
Funding IC
FY Total Cost by IC
2003
National Institute of Neurological Disorders and Stroke
$265,240
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01NS045826-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01NS045826-02
Patents
No Patents information available for 5R01NS045826-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01NS045826-02
Clinical Studies
No Clinical Studies information available for 5R01NS045826-02
News and More
Related News Releases
No news release information available for 5R01NS045826-02
History
No Historical information available for 5R01NS045826-02
Similar Projects
No Similar Projects information available for 5R01NS045826-02